Role of curcumin-dependent modulation of tumor microenvironment of a murine T cell lymphoma in altered regulation of tumor cell survival

Toxicology and Applied Pharmacology

Volumn 252, Issue 3, 2011, Pages 298-306

  Vishvakarma, Naveen Kumar ^a   Kumar, Anjani ^a   Singh, Sukh Mahendra ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Curcumin; T cell lymphoma; Tumor microenvironment; Tumor progression

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; CURCUMIN;

ACIDOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL STRUCTURE; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; FEMALE; GLUCOSE METABOLISM; HYPOXIA; MALE; MOUSE; NICK END LABELING; NONHUMAN; PH; PROTEIN EXPRESSION; T CELL LYMPHOMA; TUMOR CELL; TUMOR GROWTH; TUMOR MICROENVIRONMENT;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL GROWTH PROCESSES; CURCUMIN; FEMALE; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; HSP70 HEAT-SHOCK PROTEINS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LYMPHOMA, T-CELL; MALE; MICE; MICE, INBRED BALB C; P-GLYCOPROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPECIFIC PATHOGEN-FREE ORGANISMS; SURVIVAL ANALYSIS; TUMOR MICROENVIRONMENT; TUMOR SUPPRESSOR PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MURINAE;

EID: 79954628007     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2011.03.002     Document Type: Article

References (35)

1. Aggarwal B.B., Kumar A., Bharti A.C. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 2003, 23:363-398.
2. Airley R.E., Mobasheri A. Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeutics. Chemotherapy 2007, 53:233-256.
3. Anand P., Sundaram C., Jhurani S., Kunnumakkara A.B., Aggarwal B.B. Curcumin and cancer: an "old-age" disease with an "age-old" solution. Cancer Lett. 2008, 267(1):133-164.
4. Aoki H., Takada Y., Kondo S., Sawaya R., Aggarwal B.B., Kondo Y. Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways. Mol. Pharmacol. 2007, 72(1):29-39.
5. Bharti A.C., Singh S.M. Induction of apoptosis in bone marrow cells by gangliosides produced by a T cell lymphoma. Immunol. Lett. 2000, 72:39-48.
6. Cairns R., Papandreou I., Denko N. Overcoming physiologic barriers to cancer treatment by molecularly targeting the tumor microenvironment. Mol. Cancer Res. 2006, 4:61-70.
7. Cairns R.A., Papandreou I., Sutphin P.D., Denko N.C. Metabolic targeting of hypoxia and HIF1 in solid tumors can enhance cytotoxic chemotherapy. Proc. Natl Acad. Sci. U.S.A. 2007, 104:9445-9450.
8. Chaudhuri R.K., Mukherjee M., Sengupta D., Mazumder S. Limitation of glucose oxidase method of glucose estimation in jaundiced neonates. Indian J. Exp. Biol. 2006, 44:254-255.
9. Chiche J., Ilc K., Laferriere J., Trottier E., Dayan F., Mazure N.M., et al. Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH. Cancer Res. 2009, 69:358-368.
10. Contasta I., Berghella A.M., Pellegrini P., Adorno D. Passage from normal mucosa to adenoma and colon cancer: alteration of normal sCD30 mechanisms regulating TH1/TH2 cell functions. Cancer Biother. Radiopharm. 2003, 18:549-557.
11. De Schutter H., Landuyt W., Verbeken E., Goethals L., Hermans R., Nuyts S. The prognostic value of the hypoxia markers CA IX and GLUT 1 and the cytokines VEGF and IL 6 in head and neck squamous cell carcinoma treated by radiotherapy +/- chemotherapy. BMC Cancer 2005, 5:42.
12. de Souza L.F., Jardim F.R., Sauter I.P., de Souza M.M., Bernard E.A. High glucose increases RAW 264.7 macrophages activation by lipoteichoic acid from Staphylococcus aureus. Clin. Chim. Acta 2008, 398:130-133.
13. Fais S. Proton pump inhibitor-induced tumour cell death by inhibition of a detoxification mechanism. J. Intern. Med. 2010, 267:515-525.
14. Gupta V., Singh S.M. Gender dimorphism in the myeloid differentiation of bone marrow precursor cells in a murine host bearing a T cell lymphoma. J. Reprod. Immunol. 2007, 74:90-102.
15. Gupta V., Singh S.M. Sex dimorphism in antitumor response of chemotherapeutic drug cisplatin in a murine host-bearing a T-cell lymphoma. Anticancer Drugs 2008, 19:583-592.
16. Hamilton A., Gallipoli P., Nicholson E., Holyoake T.L. Targeted therapy in haematological malignancies. J. Pathol. 2010, 220:404-418.
17. Klausen P., Pedersen L., Jurlander J., Baumann H. Oncostatin M and interleukin 6 inhibit cell cycle progression by prevention of p27kip1 degradation in HepG2 cells. Oncogene 2000, 19:3675-3683.
18. Kunnumakkara A.B., Anand P., Aggarwal B.B. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett. 2008, 269:199-225.
19. Lardner A. The effects of extracellular pH on immune function. J. Leukoc. Biol. 2001, 69:522-530.
20. Li Z.W., Dalton W.S. Tumor microenvironment and drug resistance in hematologic malignancies. Blood Rev. 2006, 20:333-342.
21. Morita Y., Naka T., Kawazoe Y., Fujimoto M., Narazaki M., Nakagawa R., et al. Signals transducers and activators of transcription (STAT)-induced STAT inhibitor-1 (SSI-1)/suppressor of cytokine signaling-1 (SOCS-1) suppresses tumor necrosis factor alphainduced cell death in fibroblasts. Proc. Natl Acad. Sci. U.S.A. 2000, 97:5405-5410.
22. Notarbartolo M., Poma P., Perri D., Dusonchet L., Cervello M., D'Alessandro N. Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression. Cancer Lett. 2005, 224(1):53-65.
23. Pérez-Sayáns M., García-García A., Reboiras-López M.D., Gándara-Vila P. Role of VATPases in solid tumors: importance of the subunit C (Review). Int. J. Oncol. 2009, 34:1513-1520.
24. Semenza G.L. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 2010, 29:625-634.
25. Shanker A., Singh S.M., Sodhi A. Ascitic growth of a spontaneous transplantable T cell lymphoma induces thymic involution. 1. Alterations in the CD4/CD8 distribution in thymocytes. Tumour Biol. 2000, 21:288-298.
26. Shanker A., Singh S.M., Sodhi A. Ascitic growth of a spontaneous transplantable T cell lymphoma induces thymic involution. 2. Induction of apoptosis in thymocytes. Tumour Biol. 2000, 21:315-327.
27. Shishodia S., Chaturvedi M.M., Aggarwal B.B. Role of curcumin in cancer therapy. Curr. Probl. Cancer 2007, 31(4):243-305.
28. Singh M.P., Sharma H., Singh S.M. Prolactin promotes growth of a spontaneous T cell lymphoma: role of tumor and host derived cytokines. Cancer Invest. 2006, 24:601-610.
29. Singh V., Singh M.P., Singh S.M. Cell density-dependent alterations in tumorigenic potential of a murine T-cell lymphoma: implication in the evolution of multidrug resistance in tumor cells. Anticancer Drugs 2008, 19:793-804.
30. Singh V., Singh S.M. Effect of high cell density on the growth properties of tumor cells: a role in tumor cytotoxicity of chemotherapeutic drugs. Anticancer Drugs 2007, 18:1123-1132.
31. Somoza B., Guzman R., Cano V., Merino B., Ramos P., Diez-Fernandez C., et al. Induction of cardiac uncoupling protein-2 expression and adenosine 5'-monophosphate-activated protein kinase phosphorylation during early states of diet-induced obesity in mice. Endocrinology 2007, 148:924-931.
32. Sulkowska M., Wincewicz A., Sulkowski S., Koda M., Kanczuga-Koda L. Relations of TGFbeta1 with HIF-1 alpha, GLUT-1 and longer survival of colorectal cancer patients. Pathology 2009, 41:254-260.
33. Verma V.K., Singh V., Singh M.P., Singh S.M. Treadmill exercise-dependent tumor growth retardation in T-cell lymphoma-bearing host displays gender dimorphism. Oncol. Res. 2010, 18:293-304.
34. Vishvakarma N.K., Singh S.M. Immunopotentiating effect of proton pump inhibitor pantoprazole in a lymphoma-bearing murine host: implication in antitumor activation of tumor-associated macrophages. Immunol. Lett. 2010, 134:83-92.
35. Vishvakarma N.K., Singh S.M. Mechanisms of tumor growth retardation by modulation of pH regulation in the tumor-microenvironment of a murine T cell lymphoma. Biomed Phamacother. 2011, 65:27-39.